India, Sept. 15 -- Tuesday, SMA Solar Technology AG (SMTGY.PK) announced that Chief Executive Officer Jurgen Reinert informed the Supervisory Board about his illness, due to which he is unable to carr... Read More
India, Sept. 15 -- Curaleaf Holdings Inc. (CURLF) urged Aurora Cannabis Inc. (ACB.TO) shareholders to support its takeover offer. Further, Curaleaf has asked the Alberta Securities Commission or ASC t... Read More
India, Sept. 15 -- Ascendis Pharma A/S (ASND) is down 13.07 percent, losing $34.64 to $230.28 on Tuesday. The move comes after the biopharmaceutical company announced that its Board of Directors autho... Read More
India, Sept. 15 -- Attacq Ltd (ATT.JO) revealed a profit for full year that Drops, from the same period last year The company's earnings totaled ZAR1.444 billion, or ZAR2.017 per share. This compares... Read More
India, Sept. 15 -- The U.S. Food and Drug Administration has unveiled the final design of its Expedited Investigational New Drug (IND) Pilot, a new program intended to shorten the time it takes for dr... Read More
India, Sept. 15 -- Shares of Cloudastructure Inc. (CSAI) are falling about 9 percent on Tuesday morning after the company announced a nationwide partnership with SAGE Integration Holdings, LLC. The c... Read More
India, Sept. 15 -- Cryptocurrencies are trading on a deeply negative note on Tuesday morning amidst an anxious wait for the Senate's vote on the Clarity Act, scheduled for Tuesday afternoon. The Fed's... Read More
India, Sept. 15 -- GT Biopharma, Inc. (GTBP), a clinical stage immuno-oncology company developing natural killer (NK) cell engager therapies, announced that the U.S. FDA has cleared a new IND applicat... Read More
India, Sept. 15 -- After ending the previous session well off their worst levels but still mostly lower, stocks are seeing further downside during trading on Tuesday. With the downward move, the Dow h... Read More
India, Sept. 15 -- Tempest Therapeutics (TPST), a clinical-stage biotechnology company developing in vivo CAR-T therapies for cancer and autoimmune disease, announced an exclusive option agreement wit... Read More